RESEARCH ON MECHANISM OF SHENLING BAIZHU SAN ON DIABETIC OBESITY BASED ON META-ANALYSIS AND NETWORK PHARMACOLOGY

XIAOLING ZHOU; LIPING TANG; DIYAO WU; XINYOU ZHANG

doi:10.22159/ijap.2024.v16s6.SE2020

Authors

XIAOLING ZHOU Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China
LIPING TANG Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China
DIYAO WU Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China
XINYOU ZHANG Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China

DOI:

https://doi.org/10.22159/ijap.2024.v16s6.SE2020

Keywords:

Shenling baizhu san, Diabetes obesity, Mechanism, Meta analysis, Network pharmacology

Abstract

Objective: To evaluate the therapeutic effects of Shenling Baizhu San on diabetic obesity by literature meta-analysis and analyze the mechanism of Shenling Baizhu San on diabetic obesity by combining network pharmacology and animal experiment methods.

Methods: 1. Relevant literatures at home and abroad were included. The BMI, glycosylated hemoglobin (HbA1c), 2h postprandial blood glucose (2hPG), Fasting Blood Glucose (FBG), Homa-IR, waist-to-hip ratio were used as outcome indicators to evaluate the effects of Shenling Baizhu San on diabetic obesity. 2. The related genes of diabetes obesity in GEO chip were downloaded, and the targets of Shenling Baizhu San were downloaded in TCMSP, TCMID and BATMAN-TCM. Protein interaction analysis was carried out on the intersection targets of the two, and then the core target protein was screened out based on topological analysis. 3. The model of diabetic obese mice was established, and the mice were treated with Shenling Baizhu San after grouping. After two weeks, the body mass, blood sugar and Lee's index of mice in each group were measured. The volume changes of adipocytes in each group were analyzed by Hematoxylin-Eosin method, and the concentrations of cholesterol, triglyceride and core target protein in mice serum were measured.

Results: 1. A total of 9 literatures were included, the data were complete, no publication bias was found, and the evaluation was low risk. After administration of Shenling Baizhu San, the BMI, HbA1c, 2hPG, FBG, Homa-IR and waist-hip ratio of the patients were significantly improved. 2. There were 337 genes related to diabetes obesity, 2067 targets of Shenling Baizhu San and 59 intersecting targets. There were 7 signal pathways related to the effect of Shenling Baizhu San on diabetes obesity, including Biosynthesis of unsaved fatty acids, Fatty acid metabolism and so on. 3. The results of animal experiment showed that the blood glucose of mice treated with Shenling Baizhu San was not significantly changed, the body weight and Lee's index showed a significant downward trend, the fat cells were significantly reduced, and the contents of cholesterol and triglyceride, the concentration of APO-E, IGF-1 and PAI-1 protein showed a downward trend.

Conclusion: Based on the results of meta-analysis and animal experiments, Shenling Baizhu San had obvious therapeutic effect on diabetic obesity, and its mechanism may be related to influencing the synthesis of unsaturated fatty acids and fatty acids, reducing the transformation of glucose and fat, correcting the imbalance of energy metabolism in the body, and promoting the decomposition of adipose tissue by up-regulating autophagy.

Downloads

Download data is not yet available.

References

Dajin Z, Zheng Z, Nan JL. China expert consensus on relieving type 2 diabetes mellitus. Chin Gen Pract. 2021;24(32):4037-48.

Xukai W, Peng C. Is insulin resistance the cause or result of hypertension? Chin J Hypertens. 2020;28(04):302-7.

Yuan X. Thoughts and methods of traditional Chinese medicine in the treatment of metabolic syndrome. J Trad Chin Med. 2003;4:301-2.

Pingping B, Chunxiao W. Cancer prevalence and prevention practice in shanghai. Shanghai Prev Med. 2020;32(11):955-62.

NG M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C. Global regional and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766-81. doi: 10.1016/S0140-6736(14)60460-8, PMID 24880830.

Zhou Q, Chang B, Chen XY, Zhou SP, Zhen Z, Zhang LL. Chinese herbal medicine for obesity: a randomized double blinded multicenter prospective trial. Am J Chin Med. 2014;42(6):1345-56. doi: 10.1142/S0192415X14500840, PMID 25406653.

Yao Q, LI S, Cheng X, Zou Y, Shen Y, Zhang S, Yin Zhi Huang. A traditional Chinese herbal formula ameliorates diet induced obesity and hepatic steatosis by activating the AMPK/SREBP-1 and the AMPK/ACC/CPT1A pathways. Ann Transl Med. 2020;8(5):231. doi: 10.21037/atm.2020.01.31, PMID 32309378.

Zhang Y, Tang K, Deng Y, Chen R, Liang S, Xie H. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high fat diet induced NAFLD rats. Biomed Pharmacother. 2018 Jun;102:1025-36. doi: 10.1016/j.biopha.2018.03.158, PMID 29710519.

Lili T, Huiying W, Xiaoping C, sang Xia, Zeng Cheng, Xin Jun, Liu Guiying, Niu Xinyi. Effect of acupoint catgut embedding combined with spleen strengthening and expectorant traditional Chinese medicine on glucose and lipid metabolism in obese patients with polycystic ovary syndrome. J Trad Chin Med. 2010;51(03):239-42.

Guideline for prevention and treatment of type 2 diabetes in China 2017 Edition) [J]. China Journal of Practical Internal Medicine. 2018,38(04):292-344.

Junhua P, Suohua G, Huanyan Z. Effects of shen ling baizhu powder combined with metformin on miR-146a, GLP-1 and blood lipids in obese patients with type 2 diabetes mellitus. Tianjin Med. 2021;49(02):203-7.

Haiyan J, Suohua G, Xue Y. Effects of shen ling baizhu powder combined with metformin on intestinal flora in obese diabetic patients and their adverse reactions. Gansu J Sci. 2020;32(06):9-13.

Luyang S, Huanyan Z, Xue Y. Shen ling baizhu powder combined with metformin in treatment of obese patients with type 2 diabetes miR-221 MCP-1 TNF-α. Clin Lab. 2020;38(09):710-3.

Xiaoshan H. Integrated traditional Chinese and Western medicine in the treatment of obesity type 2 diabetes. J Diet Health Care. 2020;7:79.

Zhifang C. Shen ling baizhu powder in the treatment of obesity type 2 diabetes mellitus with spleen deficiency and dampness syndrome. Clinical Medical Literature Electronic Magazine. 2019;6(03):155-6.

Ningning M. Shen ling baizhu powder in the treatment of obesity type 2 diabetes mellitus with spleen deficiency and dampness syndrome. Chinese Medicine Guide. 2017;23(12):74-6.

Fujian C, Cuiling Z. Clinical study on the treatment of obesity type 2 diabetes with integrated traditional Chinese and Western medicine. Chin J Trad Chin Med. 2016;31(11):1688-90.

Xiaojuan X, Dan L, Jing W. Adjuvant treatment of 80 cases of type 2 diabetes mellitus with obesity by shen ling baizhu san. Hainan Med. 2015;26(24):3612-4.

Xiu M. Modified shen ling baizhu powder for the treatment of obesity with spleen deficiency and dampness syndrome in early stage of diabetes. J Chin Med Clin J. 2015;27(11):1583-5.

Maguire OA, Ackerman SE, Szwed SK, Maganti AV, Marchildon F, Huang X. Creatine mediated crosstalk between adipocytes and cancer cells regulates obesity driven breast cancer. Cell Metab. 2021;33(3):499-512. doi: 10.1016/j.cmet.2021.01.018, PMID 33596409.

Likun D, Cuicui L. Exploring the mechanism of treating obesity from the spleen from autophagy. Chin J Trad Chin Med. 2020;35(11):5707-9.